PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of isrnoticesInternational Scholarly Research Notices
 
Int Sch Res Notices. 2014; 2014: 485014.
Published online 2014 October 29. doi:  10.1155/2014/485014
PMCID: PMC4897219

Simple Syntheses of Two New Benzo-Fused Macrocycles Incorporating Chalcone Moiety

Abstract

Simple syntheses of the benzo-fused 26-membered macrocyclic bischalcone (19E,43E)-2.11.27.36-tetroxaheptacyclo[44.4.0.04,9.012,17.021,26.029,34.037,42]pentaconta-1(46),4(9),5,7,12(17),13,15,19,21,23,25,29,31,33,37,39,41,43,47,49-icosaene-18,45-dione (3) and the benzo-fused 13-membered macrocyclic chalcone (19E)-2.11-dioxatetracyclo[19.4.0.04,9.012,17]pentacosa-1(25),4(9),5,7,12(17),13,15,19,21,23-decaen-18-one (5) using very common starting materials and reagents are described. The compounds are new and they have been characterized from their analytical and spectral data.

1. Introduction

Chalcones (1,3-diphenyl-2-propen-1-ones) [1] are known to possess a range of important biological activities, such as antibacterial [2], antifungal [3], antileishmanial [4], antimalarial [4], antifilarial [5] anti-inflammatory [68], antiprotozoal (antileishmanial and antipanosomal) [9], antimicrobial [1013], larvicidal [14], anticonvulsant [15], anti-HIV [16], antitumor [17], and anticancer [18] activities, and they could be readily transformed into varieties of other compounds, many of which are biologically active heterocycles [19, 20]. Owing to such biological activities of chalcones, the chemical literature shows the synthesis of a wide range of chalcones and their analogues [4, 813, 2123]. Again, since macrocyclic compounds are well-known for their ability to show the important property of molecular recognition, macrocyclic systems containing the chalcone moiety are expected to generate compounds having interesting biological and material properties [24, 25]. Our research on such compounds has been initiated through the synthesis of a number of macrocyclic bis- and monochalcones reported recently [26]. In continuation of that study we have synthesized a benzo-fused 26-membered macrocyclic bischalcone, namely, (19E,43E)-2.11.27.36-tetroxaheptacyclo [44.4.0.04,9.012,17.021,26.029,34.037,42] pentaconta-1(46),4(9),5,7,12(17),13,15,19,21,23,25,29,31,33,37,39,41,43,47,49-icosaene-18,45-dione (3), and a benzo-fused 13-membered macrocyclic monochalcone, namely, (19E)-2.11-dioxatetracyclo[19.4.0.04,9.012,17] pentacosa-1(25),4(9),5,7,12(17),13,15,19,21,23-decaen-18-one (5), by use of readily available starting materials. Herein we report the synthesis of these two hitherto unknown compounds.

2. Results and Discussion

Alkylation products of salicylaldehyde and o-hydroxyacetophenone by the use of 1,2-(bis-bromobenzyl)benzene as alkylating agent were first prepared. The resulting dialdehyde (1) and diketone (2), both new compounds, were then subjected to Claisen-Schmidt reaction under high dilution condition when the macrocyclic bischalcone 3 was obtained in moderate yield (Scheme 1). In order to achieve the synthesis of 5, 2,2′-dihydroxychalcone (4) was first constructed from o-hydroxyacetophenone and salicylaldehyde by Claisen-Schmidt reaction. The reaction between 4 and 1,2-(bis-bromobenzyl)benzene was then done by following the typical procedure for alkylation of phenols (K2CO3/acetone, reflux, 12 h) (Scheme 2). This reaction gave 5 in very good yield and no trace of any macrocyclic bischalcone 7 (a possible product through bimolecular cyclization of the intermediate 6) (Scheme 3).

Scheme 1
Synthesis of the macrocyclic bischalcone 3.
Scheme 2
Synthesis of the macrocyclic monochalcone 5.
Scheme 3
A possible way of formation of macrocyclic bischalcone from 6.

The new compounds 3 and 5 were characterized from their analytical and spectral data which are presented in the Experimental Section as well as in the Supplementary File in the Supplementary Material available online at http://dx.doi.org/10.1155/2014/485014.

3. Experimental

Melting points were taken in open capillary tubes and are uncorrected. IR spectra were recorded on a Perkin Elmer FT-IR spectrophotometer (Spectrum BX II) in KBr pellets. 1H and 13C NMR spectra were recorded in CDCl3 on a Bruker AV-300 (300 MHz) spectrometer. Analytical samples were routinely dried in vacuo at room temperature. Microanalytical data were recorded on a Perkin-Elmer 2400 Series II C, H, N analyzer. ESIMS(+) mass spectrum of 3 was measured with a Waters Micromass Q-Tof micro instrument. Column chromatography was performed with silica gel (100–200 mesh) and TLC with silica gel G made of SRL Pvt. Ltd. Petroleum ether used had the boiling range of 60–80°C. 1H and 13C NMR and mass spectra of different compounds can be found in the Supplementary Material.

3.1. 1,2-Bis(bromomethyl)benzene

This compound was prepared from o-xylene by benzylic bromination with NBS [NBS (2.2 equiv.), (PhCOO)2 (trace), refluxed in CCl4, 12 h, yield: 83%), m.p. 94°C (lit. [27] 92–96°C); 1H NMR (CDCl3): δ 4.66 (br. s, 4H, –CH 2-Br), 7.29–7.31 (m, 2H, Ar-H), 7.33–7.38 (m, 2H, Ar-H).

3.2. 1,2-Bis(2-formylphenoxymethyl)benzene (1)

A mixture of salicylaldehyde (2 mmol) and 1,2-bis(bromomethyl)benzene (1 mmol) was refluxed in methanolic KOH (5%, 25 mL) for 7 h. Removal of methanol by distillation and addition of water followed by extraction with ethyl acetate gave crude alkylation product 1, which was purified by rapid column chromatography followed by crystallization from CHCl3-petroleum ether (yield: 66%). The physical and spectral data of 1 were as follows: colourless needles, m.p. 118–120°C; 1H NMR (300 MHz, CDCl3): δ 5.31 (br. s, 4H, 2 × –OCH2–), 7.05 (dt, 4H, J = 7.2 and 1.5 Hz), 7.42–7.45 (m, 2H, ArH), 7.50–7.57 (m, 4H), 7.82 (dd, 2H, J = 7.8 and 1.8 Hz), and 10.45 (br. s, 2H, 2 × –CHO).

3.3. 1,2-Bis(2-acetylphenoxymethyl)benzene (2)

A mixture of o-hydroxyacetophenone (2 mmol), 1,2-bis(bromomethyl)benzene (1 mmol) and anhydrous K2CO3 (3 g.) was refluxed in dry acetone for 12 h. Usual work-up followed by purification of the resulting crude material by column chromatography over silica gel afforded pure 2 (yield: 78%). The physical and spectral data of 2 were as follows: colourless needles (CHCl3-petroleum ether), m.p. 74°C; 1H NMR (300 MHz, CDCl3): δ 2.53 (s, 6H, 2 × –COCH3), 5.27 (br. s, 4H, –OCH2), 7.03 (dt, 4H, J = 8.4 and 1.8 Hz), 7.40–7.46 (m, 4H), 7.54 (dt, 2H, J = 8.4 and 1.8 Hz), and 7.71 (dd, 2H, J = 7.8 and 1.8 Hz).

3.4. (19E,43E)-2.11.27.36-Tetroxaheptacyclo[44.4.0.04,9.012,17.021,26.029,34.037,42]pentaconta-1(46),4(9),5,7,12(17),13,15,19,21,23,25,29,31,33,37, 39,41,43,47,49-icosaene-18,45-dione (3)

A mixture of the dialdehyde 1 (1 mmol) and the diketone 2 (1 mmol) was dissolved in a KOH solution (10%, 75 mL) in MeOH-H2O (3 : 1) and the mixture was stirred at room temperature. A precipitate began to be formed after ca. 5 h of stirring. The stirring was continued for 72 h and then the solid was collected. The solid thus obtained was almost pure and it was further purified by column chromatography over silica gel followed by crystallization from CHCl3-petroleum ether (yield: 49%). The analytical and spectral data of the macrocyclic product 3 were as follows: light yellow cubes; m.p. 205–207°C; IR (KBr, cm−1): 1598 (C=O), 1567, 1485, 1446, 1384 cm−1; 1H NMR (300 MHz, CDCl3): δ 4.85 (s, 4H, –O–CH 2–), 5.06 (s, 4H, –CH2–O–), 6.77 (d, 4H, J = 7.2 Hz), 6.80 (t, 2H, J = 7.5 Hz), 6.97 (t, 4H, J = 7.8 Hz), 7.18–7.26 (m, 10H), 7.27 (d, 2H, J = 16.2 Hz, 2 × H-α), 7.38 (dt, 2H, J = 7.5 and 1.5 Hz), 7.47 (dd, 2H, J = 8.4 and 1.5 Hz), 7.70 (d, 2H, J = 16.2 Hz, 2 × H-β); 13C NMR (75 MHz, CDCl3): δ 68.23, 68.48, 112.47, 112.75, 121.04, 121.21, 123.98, 127.65, 128.10, 128.11, 128.48, 129.40, 129.60, 130.10, 130.21, 131.47, 132.23, 133.81, 134.42, 140.17, 156.42, 157.10, 194.64 (C=O); MS (TOF MS ES+): m/z 707.18 (M+Na)+, 685.19 (M+H)+. Elemental analysis: Calcd. for C46H36O6:C, 80.68; H, 5.30. Found: C, 80.56; H 5.42%.

3.5. 2,2′-Dihydroxychalcone (4)

This chalcone was prepared by condensation of o-hydroxyacetophenone and salicylaldehyde with aqueous alkali, m.p. 162–164°C (lit. [28] 168°C). 1H NMR (300 MHz, CDCl3): δ 5.74 (br. s, 1H, 2-OH), 6.88 (br. d, 1H, J = 8.1 Hz), 6.94–7.07 (m, 3H), 7.32 (dt, 1H, J = 7.8 and 1.8 Hz), 7.52 (dt, 1H, J = 7.5 and 1.5 Hz), 7.63 (dd, 1H, J = 7.8 and 1.9 Hz), 7.87 (d, 1H, J = 15.6 Hz, H-α), 7.96 (dd, 1H, J = 8.1 and 1.5 Hz), 8.21 (d, 1H, J = 15.6 Hz, H-β), 12.92 (s, 1H, 2′-OH).

3.6. (19E)-2.11-Dioxatetracyclo[19.4.0.04,9.012,17]pentacosa-1(25),4(9),5,7,12(17),13,15,19,21,23-decaen-18-one (5)

To a mixture of 4 (1 mmol) and 1,2-bis(bromomethyl)benzene (1 mmol) in dry acetone (25 mL), anhydrous K2CO3 (3 g) was added and the mixture was refluxed with stirring for 12 h. Usual work-up of the reaction mixture followed by chromatography of the crude product over silica gel using petroleum ether-ethyl acetate (90 : 10, v/v) gave pure 5 as light yellow crystals (yield: 57%), m.p. 160–162°C, IR (KBr) cm−1: 3028, 2903, 1585, 1562, 1470, 1453, 1436, 1297, 1249, 1152, 1058, 960, 745. 1H NMR (300 MHz, CDCl3): δ 5.28 (s, 4H, 2 × ArCH2O–), 7.01–7.10 (m, 2H), 7.11 (d, 1H, J = 16.5 Hz, H-α), 7.23–7.38 (m, 7H), 7.45–7.51 (m, 2H), 7.58 (dd, 1H, J = 7.5 and 1.8 Hz, proton ortho to C=O), 7.66 (d, 1H, J = 16.5 Hz, H-β), 13C NMR (75 MHz, CDCl3): δ 68.65, 71.70, 113.51, 119.01, 121.67, 123.46, 128.43, 128.81, 129.19, 129.77, 129.79, 129.87, 130.68, 130.88, 131.89, 132.62, 135.18, 135.29, 141.56, 156.71, 156.97, 195.23. MS (TOF MS ES+): m/z (M+Na)+ 365.00. Elemental analysis: Calcd. for C23H18O3: C, 80.68; H, 5.30. Found: C, 80.45; H, 5.44%.

4. Conclusion

Thus, we report very simple syntheses of two new benzo-fused macrocycles incorporating chalcone moiety by the use of very common starting materials. The compounds may find important applications.

Supplementary Material

Supplementary Material: Two tables containing the analytical and spectral data of 3 and 5 and ten figures showing the spectra of different compounds have been given.

Acknowledgments

Financial assistance from the DST-PURSE program, Department of Chemistry, and the UGC-UPE-II program to Jadavpur University is gratefully acknowledged. The authors also acknowledge the DST-FIST program to the Department of Chemistry, Jadavpur University, for providing the NMR spectral data. Rina Mondal and Saheli Sarkar are thankful to the UGC and Swati Samanta is thankful to the CSIR, New Delhi, for their research fellowships.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

References

1. Dhar D. N. The Chemistry of Chalcones and Related Compounds. New York, NY, USA: John Wiley & Sons; 1981.
2. Solankee A., Lad S., Solankee S., Patel G. Chalcones, pyrazolines and aminopyrimidines as antibacterial agents. Indian Journal of Chemistry B. 2009;48(10):1442–1446.
3. Svetaz L., Tapia A., López S. N., et al. Antifungal chalcones and new caffeic acids esters from Zuccagnia punctata acting against soybean infecting fungi. Journal of Agricultural and Food Chemistry. 2004;52(11):3297–3300. doi: 10.1021/jf035213x. [PubMed] [Cross Ref]
4. Gutteridge C. E., Vo J. V., Tillett C. B., et al. Antileishmanial and antimalarial chalcones: synthesis, efficacy and cytotoxicity of pyridinyl and naphthalenyl analogs. Medicinal Chemistry. 2007;3(2):115–119. doi: 10.2174/157340607780059530. [PubMed] [Cross Ref]
5. Awasthi S. K., Mishra N., Dixit S. K., et al. Short report: antifilarial activity of 1,3-diarylpropen-1-one: effect on glutathione-s-transferase, a phase ii detoxification enzyme. The American Journal of Tropical Medicine and Hygiene. 2009;80(5):764–768. [PubMed]
6. Alcaraz M. J., Vicente A. M., Araico A., Dominguez J. N., Terencio M. C., Ferrándiz M. L. Role of nuclear factor-κB and heme oxygenase-1 in the mechanism of action of an anti-inflammatory chalcone derivative in RAW 264.7 cells. British Journal of Pharmacology. 2004;142(7):1191–1199. doi: 10.1038/sj.bjp.0705821. [PMC free article] [PubMed] [Cross Ref]
7. Nowakowska Z. A review of anti-infective and anti-inflammatory chalcones. European Journal of Medicinal Chemistry. 2007;42(2):125–137. doi: 10.1016/j.ejmech.2006.09.019. [PubMed] [Cross Ref]
8. Jeon J.-H., Kim S.-J., Kim C. G., Kim J.-K., Jun J.-G. Synthesis of biologically active chalcones and their anti-inflammatory effects. Bulletin of the Korean Chemical Society. 2012;33(3):953–957. doi: 10.5012/bkcs.2012.33.3.953. [Cross Ref]
9. Hayat F., Moseley E., Salahuddin A., van Zyl R. L., Azam A. Antiprotozoal activity of chloroquinoline based chalcones. European Journal of Medicinal Chemistry. 2011;46(5):1897–1905. doi: 10.1016/j.ejmech.2011.02.004. [PubMed] [Cross Ref]
10. Baviskar B., Patel S., Khadebadi S. S., Shiradkar M. Design and synthesis of some novel chalcones as potent antimicrobial agent. Asian Journal of Research in Chemistry. 2008;1(2):67–69.
11. Solankee A., Kapadia K., Soković M., Doytchinova I., Geronikaki A. Synthesis of some new S-triazine based chalcones and their derivatives as potent antimicrobial agents. European Journal of Medicinal Chemistry. 2010;45(2):510–518. doi: 10.1016/j.ejmech.2009.10.037. [PubMed] [Cross Ref]
12. Tiwari B., Pratapwar A. S., Tapas A. R., Butle S. R., Vatkar B. S. Synthesis and antimicrobial activity of some chalcone derivatives. International Journal of ChemTech Research. 2010;2(1):499–503.
13. Prasad Y. R., Rao A. L., Rambabu R. Synthesis and antimicrobial activity of some chalcone derivatives. E-Journal of Chemistry. 2008;5(3):461–466. doi: 10.1155/2008/876257. [Cross Ref]
14. Begum N. A., Roy N., Laskar R. A., Roy K. Mosquito larvicidal studies of some chalcone analogues and their derived products: structure-activity relationship analysis. Medicinal Chemistry Research. 2011;20(2):184–191. doi: 10.1007/s00044-010-9305-6. [Cross Ref]
15. Genovese S., Epifano F., Curini M., Dudra-Jastrzebska M., Luszczki J. J. Prenyloxyphenylpropanoids as a novel class of anticonvulsive agents. Bioorganic and Medicinal Chemistry Letters. 2009;19(18):5419–5422. doi: 10.1016/j.bmcl.2009.07.110. [PubMed] [Cross Ref]
16. Wu J.-H., Wang X.-H., Yi Y.-H., Lee K.-H. Anti-AIDS agents 54. A potent anti-HIV chalcone and flavonoids from genus Desmos. Bioorganic and Medicinal Chemistry Letters. 2003;13(10):1813–1815. doi: 10.1016/S0960-894X(03)00197-5. [PubMed] [Cross Ref]
17. Shibata S. Anti-tumorigenic chalcones. Stem Cells. 1994;12(1):44–52. doi: 10.1002/stem.5530120109. [PubMed] [Cross Ref]
18. Solomon V. R., Lee H. Anti-breast cancer activity of heteroaryl chalcone derivatives. Biomedicine & Pharmacotherapy. 2012;66(3):213–220. doi: 10.1016/j.biopha.2011.11.013. [PubMed] [Cross Ref]
19. Voskiene A., Mickevičius V. Cyclization of chalcones to isoxazole and pyrazole derivatives. Chemistry of Heterocyclic Compounds. 2009;45(12):1485–1488. doi: 10.1007/s10593-010-0455-8. [Cross Ref]
20. Sandeep G., Ranganath Y. S., Bhasker S., Rajkumar N. Synthesis and biological screening of some novel Coumarin derivatives. Asian Journal of Research in Chemistry. 2009;2(1):46–48.
21. Brien K. A., Bandi R. K., Behera A. K., et al. Design, synthesis and cytotoxicity of novel chalcone analogs derived from 1-cyclohexylpyrrolidin-2-one and 2,3-dihydrobenzo[f]chromen-1-one. Archiv der Pharmazie—Chemistry in Life Sciences. 2012;345(5):341–348. doi: 10.1002/ardp.201100265. [PubMed] [Cross Ref]
22. Satam V., Bandi R. K., Behera A. K., et al. Design, synthesis, and cytotoxicity of novel 3-arylidenones derived from alicyclic ketones. Chemical Biology and Drug Design. 2011;78(4):700–708. doi: 10.1111/j.1747-0285.2011.01176.x. [PubMed] [Cross Ref]
23. Satam V., Bandi R. K., Behera A. K., et al. Design, synthesis and cytotoxicity of chalcone analogs derived from 2-phenylimino-3-phenylthiazolidin-4-one. Letters in Drug Design and Discovery. 2011;8(8):704–708. doi: 10.2174/157018011796576033. [Cross Ref]
24. Matsushima R., Fujimoto S., Tokumura K. Dual photochromic properties of 4-dialkylamino-2-hydroxychalcones. Bulletin of the Chemical Society of Japan. 2001;74(5):827–832. doi: 10.1246/bcsj.74.827. [Cross Ref]
25. Rurack K., Dekhtyar M. L., Bricks J. L., Resch-Genger U., Rettig W. Quantum yield switching of fluorescence by selectively bridging single and double bonds in chalcones: involvement of two different types of conical intersections. Journal of Physical Chemistry A. 1999;103(48):9626–9635. doi: 10.1021/jp992878m. [Cross Ref]
26. Mondal R., Mandal T. K., Mallik A. K. Simple synthesis of a new family of 22- to 28-membered macrocycles containing two chalcone moieties. Arkivoc. 2012;2012(9):95–110. doi: 10.3998/ark.5550190.0013.909. [Cross Ref]
28. Alcantara A. R., Marinas J. M., Sinisterra J. V. Synthesis of 2′-hydroxychalcones and related compounds in interfacial solid-liquid conditions. Tetrahedron Letters. 1987;28(14):1515–1518. doi: 10.1016/S0040-4039(01)81030-3. [Cross Ref]

Articles from International Scholarly Research Notices are provided here courtesy of Hindawi Limited